US Patent 10246462 Chemokine receptor modulators and uses thereof

Patent 10246462 was granted and assigned to Flx Bio, Inc. on April, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10246462

Date of Patent

April 2, 2019

Patent Application Number

15700040

Date Filed

September 8, 2017

Patent Citations Received

‌

US Patent 11945785 Pyrazine compounds as inhibitors of FLT3

‌

US Patent 11878009 Anticancer combination of chidamide and celecoxib salts

Patent Primary Examiner

‌

Kahsay Habte

Patent abstract

Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of chemokine receptor activity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10246462 Chemokine receptor modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API